Page 137 - 《中国药房》2024年20期

改善，且未发生 ADR，提示奥马环素可作为青少年支原 [ 7 ] BURGOS R M，RODVOLD K A. Omadacycline：a novel
体感染治疗的新选择，但该药在青少年或儿童患者中的 aminomethylcycline[J]. Infect Drug Resist，2019，12：
有效性和安全性仍需要更多临床证据予以支持。 1895-1915.
综上所述，奥马环素的抗菌谱广，生物利用度高， [ 8 ] HUBAND M D，PFALLER M A，SHORTRIDGE D，et al.
ADR 发生率低，且不受年龄、性别、肝肾功能、药物相互 Surveillance of omadacycline activity tested against clini‐
cal isolates from the United States and Europe：results
作用的影响。但其国内临床研究数据有限，临床实际应
from the SENTRY antimicrobial surveillance programme，
用时间较短，尤其是在重症CAP或多重耐药感染患者中 2017[J]. J Glob Antimicrob Resist，2019，19：56-63.
的疗效有待进一步验证，同时单药治疗或联合其他抗菌
[ 9 ] US Food and Drug Administration. Omadacycline injec‐
药物的方案哪一个更优仍需更多临床数据支持，因此需
tion and oral products：FDA identified breakpoints for
要更多高质量的临床研究来综合评估奥马环素治疗肺 omadacycline[EB/OL].（2022-06-06）[2024-05-28].https：//
部感染的有效性和安全性。 www.fda.gov/drugs/development-resources/omadacycline-
参考文献 injection-and-oral-products.
[ 1 ] QIN T，ZHOU H J，REN H Y，et al. Incidence，etiology， [10] WAITES K B，CRABB D M，LIU Y，et al. In vitro activi‐
and environmental risk factors of community-acquired ties of omadacycline（PTK 0796）and other antimicrobial
pneumonia requiring hospitalization in China：a 3-year， agents against human Mycoplasmas and Ureaplasmas[J].
prospective，age-stratified，multicenter case-control study Antimicrob Agents Chemother，2016，60（12）：7502-7504.
[J]. Open Forum Infect Dis，2021，8（11）：ofab499. [11] KOHLHOFF S A，HUERTA N，HAMMERSCHLAG M
[ 2 ] DURÃES F，SOUSA E. Omadacycline：a newly approved R. In vitro activity of omadacycline against Chlamydia
antibacterial from the class of tetracyclines[J]. Pharmaceu‐ pneumoniae[J]. Antimicrob Agents Chemother，2019，63
ticals，2019，12（2）：63. （2）：e01907-e01918.
[ 3 ] 中华医学会，中华医学会杂志社，中华医学会全科医学 [12] SHOEN C，BENAROCH D，SKLANEY M，et al. In vitro
分会，等 . 成人社区获得性肺炎基层诊疗指南：2018 年 activities of omadacycline against rapidly growing Myco‐
[J]. 中华全科医师杂志，2019，18（2）：117-126. bacteria[J]. Antimicrob Agents Chemother，2019，63（5）：
Chinese Medical Association，Chinese Medical Journals e02518-e02522.
Publishing House Co.，Ltd.，General Practice Branch of [13] STAPERT L，WOLFE C，SHINABARGER D，et al. In
Chinese Medical Association，etc. Guideline for primary vitro activities of omadacycline and comparators against
care of adult community acquired pneumonia：2018[J]. anaerobic bacteria[J]. Antimicrob Agents Chemother，
Chin J Gen Pract，2019，18（2）：117-126. 2018，62（4）：e00018-e00047.
[ 4 ] 全国细菌耐药监测网. CHINET 2023年全年细菌耐药监 [14] WATKINS R R，DERESINSKI S. Omadacycline：a novel
测结果[EB/OL].（2024-03-05）[2024-08-22]. https：//www. tetracycline derivative with oral and intravenous formula‐
chinets.com/Content/File/CHINET%202023%E5%B9%- tions[J]. Clin Infect Dis，2019，69（5）：890-896.
B4%E7%BB% 86%E8%8F% 8C% E8%80%90%E8%- [15] LEPAK A J，ZHAO M，MARCHILLO K，et al. In vivo
8D%AF%E7%9B%91%E6%B5%8B%E7%BB%93%- pharmacodynamic evaluation of omadacycline （PTK
E6%9E%9C.pdf. 0796）against Streptococcus pneumoniae in the murine
China Antimicrobial Resistance Surveillance System. pneumonia model[J]. Antimicrob Agents Chemother，
CHINET 2023 annual bacterial resistance monitoring 2017，61（5）：e02316-e02368.
results[EB/OL].（2024-03-05）[2024-08-22]. https：//www. [16] LEPAK A J，ZHAO M，MARCHILLO K，et al. In vivo
chinets.com/Content/File/CHINET%202023%E5%B9%- pharmacodynamics of omadacycline against Staphylococcus
B4%E7%BB% 86%E8%8F% 8C% E8%80%90%E8%- aureus in the neutropenic murine thigh infection model[J].
8D%AF%E7%9B%91%E6%B5%8B%E7%BB%93%- Antimicrob Agents Chemother，2019，63（7）：e00624-e00619.
E6%9E%9C.pdf. [17] MACONE A B，CARUSO B K，LEAHY R G，et al. In
[ 5 ] 王潜，杨菊华，陈乡，等. 基于宏基因组二代测序的儿童 vitro and in vivo antibacterial activities of omadacycline，
肺炎支原体耐药基因位点分析[J]. 中华儿科杂志，2024， a novel aminomethylcycline[J]. Antimicrob Agents Che‐
62（5）：457-461. mother，2014，58（2）：1127-1135.
WANG Q，YANG J H，CHEN X，et al. Metagenomic next- [18] ENDERMANN R，LADEL C H，BROETZ-OESTERHELT
generation sequencing-based retrospective investigation of H，et al. BAY 73-7388，a novel aminomethylcycline，is
the drug resistance sites of Mycoplasma pneumoniae in highly active in vivo in a murine model of Pneumococcal
children[J]. Chin J Pediatr，2024，62（5）：457-461. pneumonia[EB/OL].[2024-08-16].https：//api.semantic‐
[ 6 ] DRAPER M P，WEIR S，MACONE A，et al. Mechanism scholar.org/CorpusID：4489448.
of action of the novel aminomethylcycline antibiotic oma‐ [19] KARLOWSKY J A，STEENBERGEN J，ZHANEL G G.
dacycline[J]. Antimicrob Agents Chemother，2014，58（3）： Microbiology and preclinical review of omadacycline[J].
1279-1283. Clin Infect Dis，2019，69（Suppl. 1）：S6-S15.

中国药房 2024年第35卷第20期 China Pharmacy 2024 Vol. 35 No. 20 · 2575 ·